Statistics from Altmetric.com
Myasthenia gravis is defined as an acquired autoimmune disorder where there is abnormal fatiguability of muscles due to deficiency of acetylcholine receptors caused by circulating antibodies directed against them.1 Ocular myasthenia is a form of myasthenia gravis clinically involving only the levator palpebrae superioris, the orbicularis oculi, and the extraocular muscles. Ptosis and ophthalmoplegia, both unilateral and bilateral, constitute the only signs in about 20% cases while in about 70% cases, ocular symptoms mark the onset of generalised myasthenia gravis.1
We examined a 10 month old male child who presented to us with complaints of ptosis and ophthalmoplegia of the right eye for a month before presentation. The child was born normally at full term to a healthy young mother with an uneventful perinatal and postnatal period. The milestones of the child were recorded as normal. The child had an older sister aged 3 years who gave no history of similar complaints. There was no history of fever, vomiting, pain, trauma, seizures, difficulty in swallowing or chewing, or any history of excessive lassitude or listlessness given by the parents with regard to the child.
General physical examination revealed a child with normal physical and mental development. Systemic examination revealed no presence of heart block or any other cardiovascular abnormality. Neurological examination revealed no motor weakness, incoordination, ataxia, or areflexia. On ocular examination, the patient had moderate ptosis of the right upper lid with absence of any voluntary movement of the right eyeball. Ocular movements of the left eye appear to be normal. The child was attentive to both visual and auditory stimuli and frequently changed his head posture to look in the direction of origin of the visual or auditory stimuli. The pupillary reactions were normal in both eyes. In the primary gaze position, the visual axes of both eyes were parallel (Fig 1). The child was examined twice after a period of sleep and similar findings were recorded again.
Examination of the anterior and posterior segment of both eyes under general anaesthesia was unremarkable. The forced duction test was negative. Based on the above findings, a tentative diagnosis of an intracranial space occupying lesion was made. However, a contrast enhanced computed tomograph (CT) scan of the head and orbit revealed no abnormalities. Cerebrospinal fluid examination was also normal.
The child was subsequently subjected to an edrophonium test (0.15 mg /kg body weight intravenously), which was unequivocally positive with complete resolution of the ptosis and ophthalmoplegia (Fig 2). A repetitive stimulation of the left median nerve demonstrated a significant decremental response (22%). Subsequently, a serum analysis of antiacetylcholine receptor binding, blocking, and modulating antibodies was performed. Abnormal titres of anti-acetylcholine receptor binding antibodies (5.8 nmol/l; normal is less than 0.8 nmol/l) were present which confirmed the diagnosis of childhood myasthenia gravis. A contrast enhanced CT scan of the thorax was normal. The child was started on tablet neostigmine 3 mg once daily along with oral prednisolone (0.5 mg/kg body weight) and followed up regularly. Marked improvement of the ptosis and ophthalmoplegia was observed which persisted at 1 year of follow up. Systemic steroids were gradually tapered off after 6 months.
Our patient was diagnosed to have juvenile myasthenia gravis, which comprises approximately 1% of all cases of myasthenia gravis.2 It is considered to be a variant of adult myasthenia with similar clinical and autoimmune mechanism of production.3 In contrast with congenital myasthenia gravis which occurs more commonly in children less than 2 years of age, has a familial mode of occurrence, and is not responsive to steroid therapy,3,4 juvenile myasthenia gravis presents usually after 5 years of age, shows no familial occurrence, and is characterised by a definite autoimmune mechanism.3,4 Though cases of juvenile myasthenia gravis with age of onset at 2 years or less3,5 have been reported, to the best of our knowledge our patient is the youngest patient with the above diagnosis reported so far. We would like to reiterate that investigations to rule out myasthenia gravis should be performed in all patients with acquired ptosis and ophthalmoplegia, irrespective of age.
No grants or sponsorships have been requisitioned for this study. The authors do not have any proprietary or financial interest in any product or procedure mentioned in the manuscript.
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.